BCL9-2 promotes early stages of intestinal tumor progression.
Brembeck FH, Wiese M, Zatula N, Grigoryan T, Dai Y, Fritzmann J, Birchmeier W.
Brembeck FH, et al. Among authors: dai y.
Gastroenterology. 2011 Oct;141(4):1359-70, 1370.e1-3. doi: 10.1053/j.gastro.2011.06.039. Epub 2011 Jun 23.
Gastroenterology. 2011.
PMID: 21703997